Recent advances in the treatment of rhinitis and rhinosinusitis.
Current rhinitis treatment is unsatisfactory for many patients, possibly because monotherapy is employed, without regard to the major presenting symptom. Recognition of the impact of rhinitis on quality of life and on associated disorders such as asthma has led to the development of guidelines, use of which has been shown to improve symptom control and quality of life compared to unguided therapy. The role of antihistamines, topical corticosteroids and anti-leukotrienes is discussed.
Scadding
G K
GK
Royal National TNE Hospital, Grays Inn Road, London WC1 X8D, UK. g.scadding@ucl.ac.uk
D000287:Administration, Topical; D000328:Adult; D000367:Age Factors; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D019317:Evidence-Based Medicine; D017408:Guidelines as Topic; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D020024:Leukotriene Antagonists / Q000627:therapeutic use*; D011788:Quality of Life; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy*; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*; D012852:Sinusitis / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D006634:Histamine H1 Antagonists; D020024:Leukotriene Antagonists